{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:15:54Z","timestamp":1786122954821,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cbi.2026.112247","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:55:59Z","timestamp":1783378559000},"page":"112247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The novel PARP-1 inhibitor BMMP-TSC bridges mitochondrial dysfunction and innate immunity via mtDNA leakage and cGAS-STING to suppress breast cancer"],"prefix":"10.1016","volume":"437","author":[{"given":"Nan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengshu","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanlong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2026.112247_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2026.104742","article-title":"Global breast cancer incidence, mortality, and survival among indigenous women: a systematic review and meta-analysis","volume":"86","author":"Brewster","year":"2026","journal-title":"Breast"},{"key":"10.1016\/j.cbi.2026.112247_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103851","article-title":"Inequality in breast cancer: global statistics from 2022 to 2050","volume":"79","author":"Liao","year":"2025","journal-title":"Breast"},{"key":"10.1016\/j.cbi.2026.112247_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216968","article-title":"EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4\/6 inhibitors in ER+ breast cancer","volume":"593","author":"Belli","year":"2024","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.cbi.2026.112247_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.188051","article-title":"Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor\u2013positive breast cancer","volume":"10","author":"Sherman","year":"2025","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.cbi.2026.112247_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41419-025-07944-y","article-title":"Inhibition of ATM enhances the immunogenicity of triple-negative breast cancer by promoting MHC-I expression","volume":"16","author":"Li","year":"2025","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cbi.2026.112247_bib6","article-title":"Cancer immunotherapy based on the bidirectional reprogramming of the tumor microenvironment by a \"Brakes Off\/Step on the Accelerator\" core-shell manganese Phosphate\/siPD-L1 modulator","volume":"5","author":"Xia","year":"2025","journal-title":"Exploration (Beijing)"},{"issue":"7","key":"10.1016\/j.cbi.2026.112247_bib7","article-title":"Radiotherapy of breast cancer: 2025 update","volume":"29","author":"Ghannam","year":"2025","journal-title":"Cancer Radiother."},{"key":"10.1016\/j.cbi.2026.112247_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/15347354251371705","article-title":"Efficacy of melatonin in alleviating radiotherapy-induced fatigue, anxiety, and depression in breast cancer patients: a randomized, triple-blind, placebo-controlled trial","volume":"24","author":"Sadeghi Yazdankhah","year":"2025","journal-title":"Integr. Cancer Ther."},{"issue":"1","key":"10.1016\/j.cbi.2026.112247_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03758-4","article-title":"Synergistic gambogic acid\/Ga3+ remodels the immunosuppressive tumor microenvironment to enhance triple-negative breast cancer therapy","volume":"23","author":"Qiu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.cbi.2026.112247_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108558","article-title":"Therapeutic approach for triple-negative breast cancer through poly (ADP-ribose) Polymerase-1 inhibitors: current update","volume":"163","author":"Das","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2026.112247_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/157488410791498798","article-title":"Inducing synthetic lethality using PARP inhibitors","volume":"5","author":"Boss","year":"2010","journal-title":"Curr. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2026.112247_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41416-024-02729-0","article-title":"PARP inhibition leads to synthetic lethality with key splicing-factor mutations in myelodysplastic syndromes","volume":"131","author":"Zhang","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.cbi.2026.112247_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cbi.2026.112247_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/annonc\/mdz012","article-title":"OlympiAD final overall survival and tolerability results: olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer","volume":"30","author":"Robson","year":"2019","journal-title":"Ann. Oncol."},{"issue":"13","key":"10.1016\/j.cbi.2026.112247_bib15","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/s41388-020-1175-x","article-title":"Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice","volume":"39","author":"Moreno-Lama","year":"2020","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.cbi.2026.112247_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010157","article-title":"Degradation of PARP1 by MARCHF3 in tumor cells triggers cCAS-STING activation in dendritic cells to regulate antitumor immunity in hepatocellular carcinoma","volume":"12","author":"Cao","year":"2024","journal-title":"J. ImmunoTher. Cancer"},{"issue":"2","key":"10.1016\/j.cbi.2026.112247_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ccell.2025.12.002","article-title":"Targeting STING to generate therapeutic anti-tumor immunity","volume":"44","author":"Fahey","year":"2026","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cbi.2026.112247_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-025-02380-0","article-title":"Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.cbi.2026.112247_bib19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.cbi.2026.112247_bib20","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1038\/s41467-022-30568-1","article-title":"STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.cbi.2026.112247_bib21","doi-asserted-by":"crossref","first-page":"9185","DOI":"10.1039\/D5NJ00904A","article-title":"Nanodrug combining chemotherapy and ferroptosis mediated cGAS-STING activation for potent antitumor immunity","volume":"49","author":"Li","year":"2025","journal-title":"New J. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2026.112247_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12964-023-01216-y","article-title":"Decreased MFN2 activates the cGAS-STING pathway in diabetic myocardial ischaemia\u2013reperfusion by triggering the release of mitochondrial DNA","volume":"21","author":"Xiong","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"5","key":"10.1016\/j.cbi.2026.112247_bib23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.celrep.2019.09.050","article-title":"Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury","volume":"29","author":"Maekawa","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cbi.2026.112247_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12951-026-04203-w","article-title":"Nanomedicine leverages cuproptosis-mediated cGAS-STING activation to enhance antitumor immunity","volume":"24","author":"Li","year":"2026","journal-title":"J. Nanobiotechnol."},{"issue":"7548","key":"10.1016\/j.cbi.2026.112247_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature14156","article-title":"Mitochondrial DNA stress primes the antiviral innate immune response","volume":"520","author":"West","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2026.112247_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156158","article-title":"Mitochondrial DNA release and cGAS-STING activation: emerging insights into anti-tumor immunity","volume":"273","author":"Aloraini","year":"2025","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.cbi.2026.112247_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12964-021-00738-7","article-title":"Mitochondrial DNA leakage induces odontoblast inflammation via the cGAS-STING pathway","volume":"19","author":"Zhou","year":"2021","journal-title":"Cell Commun. Signal."},{"issue":"11","key":"10.1016\/j.cbi.2026.112247_bib28","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.celrep.2018.11.054","article-title":"PARP inhibition elicits STING-dependent antitumor immunity in Brca1-Deficient ovarian cancer","volume":"25","author":"Ding","year":"2018","journal-title":"Cell Rep."},{"issue":"7661","key":"10.1016\/j.cbi.2026.112247_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cbi.2026.112247_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009032","article-title":"PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF-caspase 8-GSDMD\/E axis in ovarian cancer","volume":"12","author":"Xia","year":"2024","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.cbi.2026.112247_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118312","article-title":"Discovery of novel thiosemicarbazone dimers as effective inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) for use in cancer therapy","volume":"302","author":"Wang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112247_bib32","article-title":"Optimization and comparison of different methods for assessing cell viability in intervertebral disc organ cultures","volume":"vol. 14","author":"Muerner","year":"2026"},{"issue":"6","key":"10.1016\/j.cbi.2026.112247_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70273","article-title":"Olaparib triggers mitochondrial fission through the CDK5\/Drp-1 signaling pathway in ovarian cancer cells","volume":"39","author":"Gao","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"17","key":"10.1016\/j.cbi.2026.112247_bib34","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1093\/nar\/gkad659","article-title":"Absence of mitochondrial SLC25A51 enhances PARP1-dependent DNA repair by increasing nuclear NAD+ levels","volume":"51","author":"G\u00fcldenpfennig","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cbi.2026.112247_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41420-022-01046-w","article-title":"Mitochondrial damage and activation of the cytosolic DNA sensor cGAS\u2013STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice","volume":"8","author":"Yan","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cbi.2026.112247_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.156729","article-title":"Zn2+enhanced the anti-breast cancer activity of fucoidan based nanoparticles by activating the cGAS-STING pathway","volume":"500","author":"Xue","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.cbi.2026.112247_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS\u2013STING pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discov."},{"issue":"13","key":"10.1016\/j.cbi.2026.112247_bib38","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1039\/D4NR04944F","article-title":"H2O2 self-supplying nanoparticles for chemodynamic and synergistic photodynamic therapy to augment cGAS\/STING activation","volume":"17","author":"Zhang","year":"2025","journal-title":"Nanoscale"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726003558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726003558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T13:01:06Z","timestamp":1786107666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726003558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S0009279726003558"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112247","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel PARP-1 inhibitor BMMP-TSC bridges mitochondrial dysfunction and innate immunity via mtDNA leakage and cGAS-STING to suppress breast cancer","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112247"}}